Search clinical trials for: PBF PLLA microsphere (injectable poly-L-lactic acid)

Total 28 results

Taipei Medical University Hospital
Taipei Medical University; Panion & BF Biotech Inc.

Recruiting

Polymeric Microspheres vs Sculptra® in the Treatment of Moderate to Severe Nasolabial Folds

Nasolabial Fold Wrinkles

Taiwan
Sinclair Pharmaceuticals Limited

Not yet recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit

Jawline Contour Deficit

China
Bausch Health Americas, Inc.

Completed

DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles

Nasolabial Fold Wrinkles

United States
Bausch Health Americas, Inc.

Completed

DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up

Nasolabial Fold Wrinkles

United States
UMC Utrecht

Terminated

Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors (HIT)

Head and Neck Neoplasms | Radioisotopes

Netherlands
Bausch Health Americas, Inc.

Completed

A Single-Center, Open-Label, Exploratory Study of the Volumizing Effect of SCULPTRA Measured by Three Dimensional Digital Surface Imaging

Mid Facial Contour Deficiencies

United Kingdom
UMC Utrecht

Unknown

Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization (SIM)

Liver Diseases | Digestive System Neoplasms | Neoplasm Metastasis | Colorectal Neoplasms

Netherlands
Williams Center Plastic Surgery Specialists
Sanofi

Completed

Volume Restoration of the Aging Midface With Sculptra Aesthetic

Problem of Aging

United States
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Not yet recruiting

Injectable Poly-L-Lactic Acid for Volumization and Adipogenesis of the Hip Dell

Skin Laxity

United States
Bausch Health Americas, Inc.

Completed

Biopsy Study for Sculptra (Poly-L-Lactic Acid)

Healthy Volunteers

Canada
Galderma R&D

Completed

An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area

Wrinkles in Decolletage

United States
Bausch Health Americas, Inc.

Completed

Canadian Aesthetic Experience With Sculptra Therapy

Skin Aging

Canada
Galderma Brasil Ltda.

Completed

Efficacy and Safety of Poly-L-lactic Acid (Sculptra)

Flaccidity, Muscle

Brazil
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Not yet recruiting

Sculptra to Aid in Treatment of Arm Laxity

Skin Laxity
Bausch Health Americas, Inc.

Completed

Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study) (FACES)

Facial Lipoatrophy

United States
Erevna Innovations Inc.

Completed

Efficacy and Safety of Poly-L-lactic Acid

Buttock Contouring | Buttock Lifting

Canada
Bausch Health Americas, Inc.

Completed

Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring

Acne Vulgaris

Canada
UMC Utrecht

Completed

Radioactive Holmium Microspheres for the Treatment of Liver Metastases (HEPAR)

Liver Tumors | Liver Metastasis

Netherlands
Henry Ford Health System
Galderma R&D

Completed

Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae (FADeS)

Striae Distensae

United States
Sadick Research Group

Completed

Poly-L-lactic Acid for Skin Quality

Skin Aging

United States
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Completed

Sculptra Aesthetic for the Treatment of Upper Knee Skin Laxity

Knee | Lax Skin

United States
Galderma R&D

Completed

Sculptra Aesthetic Post-Approval Study

Wrinkles | Nasolabial Fold Contour Deficiencies

United States
Shire Regenerative Medicine, Inc.

Terminated

A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing

Epidermolysis Bullosa

United States, Spain, Austria, Canada, France, Germany, Poland, Portugal
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Gilead Sciences; Hoffmann-La... and other collaborators

Terminated

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

HIV Infections | HIV-Associated Lipodystrophy

Australia
Yardley Dermatology Associates
Galderma R&D

Completed

The Emotional and Functional Benefits of Poly-L-Lactic Acid

Facial Volume Loss
Ulthera, Inc

Completed

Ultherapy™ Treatment Following Sculptra® Treatment

Skin Laxity

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant

Refractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Primary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditions

United States

Search clinical trials for: PBF PLLA microsphere (injectable poly-L-lactic acid)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations